2-108451052-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_181453.4(GCC2):c.88C>A(p.Leu30Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000345 in 1,612,784 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_181453.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCC2 | NM_181453.4 | c.88C>A | p.Leu30Ile | missense_variant | 3/23 | ENST00000309863.11 | NP_852118.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCC2 | ENST00000309863.11 | c.88C>A | p.Leu30Ile | missense_variant | 3/23 | 5 | NM_181453.4 | ENSP00000307939.5 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000497 AC: 125AN: 251272Hom.: 0 AF XY: 0.000545 AC XY: 74AN XY: 135808
GnomAD4 exome AF: 0.000334 AC: 488AN: 1460474Hom.: 1 Cov.: 29 AF XY: 0.000355 AC XY: 258AN XY: 726690
GnomAD4 genome AF: 0.000446 AC: 68AN: 152310Hom.: 0 Cov.: 33 AF XY: 0.000389 AC XY: 29AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.88C>A (p.L30I) alteration is located in exon 3 (coding exon 3) of the GCC2 gene. This alteration results from a C to A substitution at nucleotide position 88, causing the leucine (L) at amino acid position 30 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
GCC2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 26, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at